The Moore Group - Cell-Free Synthetic Biology

We work within the area of cell-free synthetic biology to study major research challenges, such as antibiotics and drug discovery.

We have specific interest in cell-free transcription-translation (TX-TL) systems, which enable rapid prototyping to study a range of applications: biosynthesis, screening, biosensors, genetic design, protein production etc.

Cell-free transcription-translation (TX-TL)

Cell-free TX-TL systems require a cell-extract, DNA and an energy solution, to make mRNA and proteins within seconds to minutes. TX-TL offers a wealth of opportunities within synthetic biology and industrial biotechnology. For further details see the research pages.

The Moore group is part of the Industrial Biotechnology research theme at the School of Biosciences, University of Kent. We acknowledge funding from the following sources: Wellcome Trust, Leverhulme Trust, GCRF, EPSRC, Royal Society and Biochemical Society.

Dr Simon Moore and Dr Andrew Lawrence groups, School of Biosciences, University of Kent - November 2021